A combination of gemcitabine and 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)Stefano Cascinu, Giuseppina Catalano, Roberto Labianca et al.|British Journal of Cancer|1999Cited by 82
The use of bone-modifying agents in early breast cancer: AIOM Guidelines update and perspectivesStefania Gori, Riccardo Gerosa, Michela Cinquini et al.|Tumori Journal|2025Cited by 1